Beta HCG, Plasma (Tumor Marker)
Tests:Beta HCG, Plasma (Tumor Marker)
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | THCG |
| Synonyms | Tumour Marker - BHCG
HCG - tumour marker BHCG - tumour marker Human Beta chorionic gonadotrophin |
| Test Availability | Monday - Sunday, testing routinely available out of hours |
| Turnaround Time | 1 – 2 hours |
| Stability – Add test | 24 Hours unseparated
7 days if separated |
Specimen Requirements | |
| Specimen Type | Plasma
Serum |
| Specimen Transportation | |
| Preferred | 7 mL plain red-top |
| Acceptable | 5 mL Li-Hep green-top |
| Unacceptable | |
| Pediatric Requirements | 200 µL Green-Top or Red-Top |
Aliquot Requirements | |
| Sample Type | Serum
Plasma |
| Preferred Volume | 200 µL Serum or Li Heparin Plasma |
| Minimum Volume | |
| Aliquot Transportation | |
Clinical Information | |
| Reference Intervals | Reference Range 0-5 IU/L (non pregnant adult) |
| Test Method | Abbott Alinity i series analyser using Abbott reagents. Chemiluminescent microparticle immunoassay. |
| Advanced Notice | Not required |
| Patient Preparation | Not required |
Comments | |
| HCG test is not suitable for the primary diagnosis of malignancy.
If HCG level is not consistent with the clinical status, results should be confirmed by an alternative method, which may include qualitative urine testing. For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |
| Owner | Clair Crossley (Crossley1) |
|---|---|
| Last reviewed | 23 Sep 2026 |
| Next review | 23 Sep 2027 OK |